BAY y 5959

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1997-2003
01219972003

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2003
2003
We examined the effects of gender and aging on cardiac and peripheral hemodynamic responses to beta-adrenergic receptor (beta-AR… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
1998
1998
BAY y 5959 is a dihydropyridine derivative with positive inotropic actions mediated by a direct increase in intracellular calcium… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
1998
1998
BAY y 5959 is a dihydropyridine derivative that binds to L-type calcium channels in a voltage-dependent manner and promotes… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
1998
1998
BACKGROUND The aim of this study was to determine the mechanism by which the calcium channel promoter BAY y 5959 affects the… (More)
  • table 1
  • table 2
  • table 3
  • figure 2
  • figure 1
Is this relevant?
1998
1998
The goal of this study was to compare responses to a calcium promoter, BAY y 5959, and dobutamine (Dob) in heart failure (HF… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
1997
1997
Traditional inotropic agents, e.g., those that increase myocardial contraction through enhanced cyclic AMP or those that increase… (More)
Is this relevant?
1997
1997
OBJECTIVES The aim of this study was to assess the cardiovascular effects of BAY y 5959, a calcium promoter modulating myocardial… (More)
Is this relevant?